14 de diciembre de 2016 / 12:43 / en un año

BRIEF-Protalix BioTherapeutics says Brazilian Ministry of Health intends to buy $24 mln of alfataliglicerase

Dec 14 (Reuters) - Protalix BioTherapeutics Inc

* Protalix BioTherapeutics - received letter from arm of Brazilian Ministry Of Health, detailing intended purchases by ministry of alfataliglicerase

* Company estimates total revenues from these shipments to be approximately $24 million in aggregate.

* Anticipated revenues could reduce co’s cash consumption rate by as much as a third in 2017

* Protalix BioTherapeutics receives letter detailing intended purchases of approximately $24 million of alfataliglicerase to treat gaucher patients in Brazil

* Protalix BioTherapeutics - letter requests three shipments of alfataliglicerase; first shipment to be made in middle of 2017, and last at end of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below